€15 Million Global Trial to Test Phage Therapy as Antibiotic Alternative

€15 Million Global Trial to Test Phage Therapy as Antibiotic Alternative

A €15 million global trial will be conducted to test phage therapy as an alternative to antibiotics for recurrent urinary tract infections. The trial, which will involve over 1,000 patients, aims to evaluate the safety and efficacy of phage therapy in treating this common condition. Phage therapy involves using viruses to target and kill bacteria, and it has shown promise in treating various infections. The trial is being led by a team of researchers from the University of Oxford.